Titan Pharmaceuticals (NASDAQ:TTNP) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Down 3.1 % Shares of TTNP opened at $3.66 on Thursday. The stock has a […]
